mardi 27 mars 2018

Onco Actu du 27 mars 2018

2. Etiologie

Development of cancer - the luck of the draw? [Institute of Cancer Research]

3.1.1 Prévention - Tabac - e-cigs

Some e-cigarette users may struggle to quit smoking [Reuters]

3.7 Prévention - Alcool

Lethal labels: Alcohol makers fight to avoid the tobacco taboo [Politico]

4.5 Dép., diag. & prono. - Colorectal

Thousands of bowel cancer patients at risk as hospitals ignore genetic test [The Telegraph]

5. Traitements

Women report fewer adverse side-effects from partial or reduced breast radiotherapy, reveals major study [Institute of Cancer Research]

5.12.2 Immunothérapies - CAR-T

Roswell Park Research on Survivin Opens Up New Avenues for Cancer Immunotherapy [Roswell Park]

5.12.3 Immunothérapies-combinaisons

Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week [FiercePharma]

5.12.5 Immunothérapies - Pharma

Gilead cancer research director heads to Compugen [FierceBiotech]

The next drug commodity play? China’s biopharmas crowding into a global PD-1/L1 free-for-all [EndPoints]

5.12.6 Immunothérapies - AMM

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo Four-Week Dosing Schedule for Advanced Melanoma and Previously Treated Renal Cell Carcinoma [BMS]

5.2 Pharma

Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer [Seattle Genetics]

Bayer announces completion of rolling submission of New Drug Application in the U.S. for larotrectinib for the treatment of TRK fusion cancer [Bayer]

AI. Telemedicine. Quantum. New Novartis Boss Says Tech Will Finally Change The Drug Biz [Forbes]

FDA hands a ‘breakthrough’ designation to Seattle Genetics’ pivotal-stage cancer drug enfortumab [EndPoints]

5.4 Traitements - Economie

A billionaire couple is pumping money into the drug pricing debate. Can they loosen pharma’s grip? [STAT]

6. Lutte contre les cancers

The people that make radiotherapy possible: Part 1 – therapy radiographers [Cancer Research UK]

The World Health Organization: Integrating quackery into the ICD-11 [Respectful Insolence]

6.1 Observation

Higher Risk of Heart Failure Seen in Some Cancers [NCI]

6.10.1 Politiques (USA)

A ‘right-to-try’ explainer [The Incidental Economist]

6.3 Associations/Fondations

She Was Given Three Years To Live. So She Transformed Cancer Research [Forbes]

6.7.1 Bioinformatique

Over 500 researchers granted access to the Genomics England Research Environment [Genomics England]